Many people living with chronic conditions are curious about PEMF and what research has looked at so far.
According to the Centers for Disease Control, 6 in 10 Americans suffer from a chronic disease, with four in ten having two or more simultaneously. Chronic diseases are the leading causes of death and disability in the US, and drive trillions of dollars annually in health care costs.
Pulsed electromagnetic field (PEMF) devices are non-invasive, and researchers have studied PEMF in a number of chronic conditions. Here is an overview of what they have looked at.
What is Electromagnetic Pulse Therapy and How Does it Work?
The human body has unique bio-electromagnetic fields that play a part in how cells communicate. PEMF devices apply pulsed magnetic fields from outside the body, and researchers are still studying how cells respond to them, mostly in lab studies so far.
The pulsed electromagnetic fields used in PEMF therapy vary in frequency and intensity from device to device. PEMF devices send out pulsed electromagnetic fields through a full body or local applicator.
Harmful EMFs (ElectroMagnetic Fields) are a hot topic, and there can be confusion around the PEMFs used in home devices. PEMF therapy uses pulsed electromagnetic fields that are low in both intensity and frequency, unlike those environmental EMFs you hear about.
What Have Researchers Studied in Chronic Conditions?
There is a growing body of PEMF research, but it varies widely in the devices used and in the intensity and frequency of sessions, and many of the studies are small. Here are a few examples.
One randomized, double-blind, sham-controlled clinical trial found that patients with fibromyalgia who had chronic generalized pain experienced pain reduction when exposed to PEMF twice daily for 40 minutes for 7 days using a portable device attached to their head.1 This trial was small, and larger studies are needed before drawing firm conclusions.
Another study looked at low back pain, one of the most common chronic pain conditions. This small pilot study reported improved function in people with non-specific low back pain who used PEMF, in line with earlier findings.2
Researchers are also exploring PEMF in autoimmune conditions such as rheumatoid arthritis (RA). A 2019 review looked at how PEMF affects certain stromal cells involved in inflammation and immunity in RA; this research is still at an early, largely laboratory stage.3
Most of this research used clinic or lab devices with different settings from FlexPulse, and no study has tested FlexPulse itself.
Why Own a Portable PEMF Device?
When considering a PEMF device, it’s important to understand which system will best suit your needs and lifestyle, including the intensity, frequency and programs it offers.
The FlexPulse PEMF therapy device is convenient and flexible, as it can be used on the go. The wearable device can be used at work, while exercising, and even overnight. The compact, lightweight device offers up to 12 hours of continuous battery power and intensities up to 200 Gauss. It can be placed on different areas of the body, including the head.
The FlexPulse is an affordable, flexible PEMF device that fits easily into your daily routine.
FlexPulse comes with a 30-day satisfaction guarantee and a 2-year warranty on the controller (see our Guarantee & Warranty page for the full terms). Contact us today for more information about PEMF and the FlexPulse.
References
- Thomas, A. W., Graham, K., Prato, F. S., McKay, J., Forster, P. M., Moulin, D. E., & Chari, S. (2007). A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain. Pain research & management, 12(4), 249–258. https://doi.org/10.1155/2007/626072
- Lisi AJ, Scheinowitz M, Saporito R, Onorato A. A Pulsed Electromagnetic Field Therapy Device for Non-Specific Low Back Pain: A Pilot Randomized Controlled Trial. Pain Ther. 2019 Jun;8(1):133-140. doi: 10.1007/s40122-019-0119-z. Epub 2019 Mar 12. PMID: 30868475; PMCID: PMC6513933.
Ross CL., Ang DC., Almeida-Porada G. Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis Front. Immunol., 04 March 2019 | https://doi.org/10.3389/fimmu.2019.00266
